Literature DB >> 34181187

Breast conserving surgery versus salvage mastectomy for ipsilateral breast cancer recurrence: a propensity score matching analysis.

Damiano Gentile1,2, Andrea Sagona3, Erika Barbieri3, Lidija Antunovic4, Davide Franceschini5, Agnese Losurdo6, Bethania Fernandes7, Corrado Tinterri3,8.   

Abstract

Salvage mastectomy is regarded as the treatment of first choice for ipsilateral breast cancer recurrence (IBCR), even if a second breast conserving surgery (BCS) is feasible. The purpose of this study was to compare the long-term oncological outcomes of IBCR patients who had undergone either mastectomy or second BCS, performing a propensity score matching (PSM) analysis to reduce the selection bias. All the consecutive patients with IBCR were retrospectively reviewed and divided into two different groups of treatment: repeat BCS versus salvage mastectomy. The propensity score predicting the probability of surgical treatment was determined for each patient and a 1:1 matching was performed. Disease-free survival (DFS), distant disease-free survival (DDFS), overall survival (OS), and breast cancer-specific survival (BCSS) were analyzed and compared between the two groups. A total of 309 patients underwent surgical treatment for IBCR. After PSM, 108 patients treated with repeat BCS and 108 patients treated with salvage mastectomy were included in the analysis. There was no significant difference in terms of DFS between patients with IBCR receiving repeat BCS or salvage mastectomy (p = 0.167). However, patients with IBCR undergoing second BCS had significantly better DDFS, OS, and BCSS compared to salvage mastectomy (p < 0.001). Salvage mastectomy should not be considered the optimal treatment for IBCR and it does not seem to improve prognosis compared to repeat conserving surgery. Second BCS for IBCR is a safe option with encouraging long-term oncological outcomes and should be proposed to all patients, when technically feasible.
© 2021. Italian Society of Surgery (SIC).

Entities:  

Keywords:  Breast cancer; Breast-conserving surgery; Mastectomy; Recurrence

Mesh:

Year:  2021        PMID: 34181187     DOI: 10.1007/s13304-021-01122-3

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  36 in total

1.  Rates of Neoadjuvant Chemotherapy and Oncoplastic Surgery for Breast Cancer Surgery: A French National Survey.

Authors:  Krishna B Clough; Victor Acosta-Marín; Claude Nos; Séverine Alran; Philippe Rouanet; Jean-Rémi Garbay; Sylvia Giard; Jean-Luc Verhaeghe; Gilles Houvenaeghel; Bernard Flipo; Jacques Dauplat; Pierre Hervé Dorangeon; Jean-Marc Classe; Roman Rouzier; Pascal Bonnier
Journal:  Ann Surg Oncol       Date:  2015-02-10       Impact factor: 5.344

2.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.

Authors:  Irene L Wapnir; Stewart J Anderson; Eleftherios P Mamounas; Charles E Geyer; Jong-Hyeon Jeong; Elizabeth Tan-Chiu; Bernard Fisher; Norman Wolmark
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

3.  Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review.

Authors:  Coco J E F Walstra; Robert-Jan Schipper; Ingrid G M Poodt; Yvonne E van Riet; Adri C Voogd; Maurice J C van der Sangen; Grard A P Nieuwenhuijzen
Journal:  Eur J Surg Oncol       Date:  2019-02-10       Impact factor: 4.424

4.  Factors predicting in-breast tumor recurrence after breast-conserving surgery.

Authors:  Robert Mechera; Carsten T Viehl; Daniel Oertli
Journal:  Breast Cancer Res Treat       Date:  2008-09-25       Impact factor: 4.872

5.  Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancer.

Authors:  Takashi Yoshida; Hiroyuki Takei; Masafumi Kurosumi; Jun Ninomiya; Yuko Ishikawa; Yuji Hayashi; Katsunori Tozuka; Hanako Oba; Kenichi Inoue; Toshio Tabei
Journal:  Breast       Date:  2009-07-21       Impact factor: 4.380

6.  Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).

Authors:  Mehra Golshan; Constance T Cirrincione; William M Sikov; Donald A Berry; Sara Jasinski; Tracey F Weisberg; George Somlo; Clifford Hudis; Eric Winer; David W Ollila
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

7.  Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG).

Authors:  D Curran; J P van Dongen; N K Aaronson; G Kiebert; I S Fentiman; F Mignolet; H Bartelink
Journal:  Eur J Cancer       Date:  1998-02       Impact factor: 9.162

8.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

9.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

Authors:  Umberto Veronesi; Natale Cascinelli; Luigi Mariani; Marco Greco; Roberto Saccozzi; Alberto Luini; Marisel Aguilar; Ettore Marubini
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

10.  Very low local recurrence rates after breast-conserving therapy: analysis of 8485 patients treated over a 28-year period.

Authors:  S C J Bosma; F van der Leij; E van Werkhoven; H Bartelink; J Wesseling; S Linn; E J Rutgers; M J van de Vijver; P H M Elkhuizen
Journal:  Breast Cancer Res Treat       Date:  2016-03-23       Impact factor: 4.872

View more
  2 in total

1.  A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence.

Authors:  Clare Josephine Tollan; Eirini Pantiora; Antonios Valachis; Andreas Karakatsanis; Marios Konstantinos Tasoulis
Journal:  Ann Surg Oncol       Date:  2022-07-18       Impact factor: 4.339

2.  Salvage Mastectomy Is not the Treatment of Choice for Aggressive Subtypes of Ipsilateral Breast Cancer Recurrence: A Single-Institution Retrospective Study.

Authors:  Damiano Gentile; Andrea Sagona; Ruggero Spoto; Davide Franceschini; Stefano Vaccari; Valeriano Vinci; Ersilia Biondi; Lorenzo Scardina; Corrado Tinterri
Journal:  Eur J Breast Health       Date:  2022-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.